ClinicalTrials.gg
WithdrawnNCT03488121Updated Sep 10, 2022

Randomized Controlled Study to Incentivize Doctors for Appropriate Use of Medical Care in NL

An interventional study of Poster and Thank-you Letter in Prescription Practices of Family Physicians in NL, sponsored by Memorial University of Newfoundland. Withdrawn at 1 site in Canada. Per ClinicalTrials.gov, last updated 2022-09-10.

Sponsored by Memorial University of Newfoundland · Not applicable, Interventional, and Health services research

Why this study was withdrawn
The study was terminated due to logistical reasons
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Sex
All
01

Study summary

Choosing Wisely Canada is a campaign for promoting appropriate use of medical services to reduce unnecessary prescribing and unnecessary diagnostic tests. Its success depends on physicians' uptake of the campaign's recommendations on appropriate use of health care. This study will conduct a cluster-randomized controlled trial to evaluate the effects of two low-cost incentives for physicians to promote their uptake of Choosing Wisely recommendations in Newfoundland and Labrador (NL). The first incentive involves placing a motivational poster in a physician's examination room. These posters will contain motivational messages about the important roles that doctors and patients can play in reducing unnecessary care. The second incentive involves sending thank-you letters to physicians to recognize their contribution in reducing unnecessary care, and thus, 'nudge' them into following recommendations. The study will evaluate the effects of the incentives on physicians' prescribing of antibiotics and serum ferritin tests. Potential cost savings of implementing the two incentives will also be estimated.

Read the detailed description

The study will employ a prospective, cluster randomized controlled trial design and will involve fee-for-service family physicians in NL. Randomization will be performed at the clinic level and stratified by clinic size. Clinics will be randomized into one of four groups: i) the control group will not receive any incentive; ii) the poster group will receive posters only; iii) the letter group will receive thank-you letters only; and iv) the double incentive group will receive both posters and thank-you letters. The number of clinics in each group will be equal.

The study will test two interventions. First, it will examine the impact of placing a poster in a physician's examination room containing motivational messages about the important roles that doctors and patients can play in reducing unnecessary care. The second incentive will involve sending thank-you letters to physicians aiming to encourage them to following Choosing Wisely's recommendations by recognizing their contribution in reducing unnecessary care. The study will focus on physicians' prescribing of antibiotics and serum ferritin tests. The posters will be designed to contain inspirational messages and pictures that highlight the important and unique roles that physicians and patients play in reducing unnecessary care and health care costs. These will be displayed in physicians' examination rooms so that they are salient to doctors and patients. The thank-you letters will contain two types of information: the changes in the rates of antibiotics and serum ferritin tests ordered since Choosing Wisely NL's introduction and a thank you message from the NL Medical Association (NLMA). These will be sent to doctors quarterly (to reinforce the message) with the changes in the rates of antibiotics and serum ferritin tests ordered being updated.

These incentives will be delivered over a 12-month period. The researchers will measure changes in the study outcomes at the end of this 12-month intervention period. Further, to examine if the effects of the intervention are sustained, these changes will be evaluated again 6 months after the withdrawal of incentives. The two incentives will be delivered via NLMA to its member family physicians. As such, physicians will be blinded to this study (i.e., they would not know that these posters and letters are part of a study). The study will focus on fee-for-service physicians in NL as data on the number of patients are only available for these physicians.

02

Conditions studied

  • Prescription Practices of Family Physicians in NL
03

In context

Lead sponsor

Memorial University of Newfoundland is the lead sponsor of 49 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All Fee-For-Service family physicians registered with the NL Medical Association

Exclusion criteria

Exclusion Criteria:

  • Salary based family physicians
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Poster Only

    This arm will only receive motivational posters.

    Behavioral: Poster

  • Experimental
    Thank-you Letter Only

    This arm will only receive thank-you letters.

    Behavioral: Thank-you Letter

  • Experimental
    Double Incentive

    This arm will receive both motivational posters and thank-you letters.

    Behavioral: Poster · Behavioral: Thank-you Letter

  • No intervention
    Control

    This arm will not receive any intervention.

Interventions

  • BehavioralPoster

    Posters contain inspirational messages and pictures highlighting the important and unique roles that patients and physicians can play in reducing unnecessary care and health care costs. These posters will be placed in physician offices.

  • BehavioralThank-you Letter

    Physicians will be sent thank-you letters containing changes in the rates of antibiotics and serum ferritin tests ordered since introduction of Choosing Wisely NL and a thank-you message from the NL Medical Association.

06

What researchers measure

Primary outcomes

  1. Rate of antibiotic prescriptions

    Rate of antibiotic prescriptions will be calculated as the number of antibiotic prescriptions per patient.

    Time frame: 12 months

  2. Rate of ordering of serum ferritin tests

    Rate of serum ferritin tests ordered will be calculated as the number of serum ferritin tests ordered per patient.

    Time frame: 12 months

Secondary outcomes

  1. Cost savings from implementing the incentives

    Cost savings for 'Poster Only' arm: To estimate cost savings for this arm, reductions in prescription of antibiotics and serum ferritin tests in this arm (relative to control arm) estimated by the RCT will be converted into monetary values using pricing data from the literature. Cost savings for 'Thank-you Letter Only' arm: To estimate cost savings for this arm, reductions in prescription of antibiotics and serum ferritin tests in this arm (relative to control arm) estimated by the RCT will be converted into monetary values using pricing data from the literature. Cost savings for 'Double Incentive' arm: To estimate cost savings for this arm, reductions in prescription of antibiotics and serum ferritin tests in this arm (relative to control arm) estimated by the RCT will be converted into monetary values using pricing data from the literature. Total cost savings will then be compared with total cost of implementing the associated incentive to estimate total net cost savings.

    Time frame: 12 months

07

Study locations

1 site
  • School of Pharmacy, Memorial University of Newfoundland
    St. John's, Newfoundland and Labrador A1B 3V6, Canada
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 10, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03488121
Lead sponsor
Memorial University of Newfoundland
Responsible party
Hai Van Nguyen (Assistant Professor, Memorial University of Newfoundland) — Principal investigator
First posted
Apr 4, 2018
Start date
Sep 1, 2018
Primary completion
May 31, 2020 (estimated)
Completion
May 31, 2020 (estimated)
Last update
Sep 10, 2022

Study contacts

Hai Nguyen, PhD
principal investigator · Memorial University of Newfoundland

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion